FREE Account Opening + No Clearing Fees
September 27, 2011 - September 29, 2011

Tijaria Polypipes IPO Review & Recommendations

Dilip Davda and MLR Securities Private Ltd recommend to "Avoid" the IPO.

Tijaria Polypipes IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 2 0
% 0.00 0.00 0.00 100.00 0.00

Tijaria Polypipes IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Dilip Davda Avoid
MLR Securities Private Ltd Avoid

Tijaria Polypipes IPO Capital Market Rating

The Captial Market ( rating for Tijaria Polypipes IPO is 15. Their analysis recommends Do not subscribe for the IPO.

Reviewer Rating Score Rating
Capital Market 15 Do not subscribe

Tijaria Polypipes IPO Review by Dilip Davda (Avoid)

[Dilip Davda]  Avoid. For 2010-11 it posted net profit of Rs. 6.90 crore on a turnover of Rs. 118.60 crore that gives EPS of Rs. 2.80 on the post IPO equity translating in P/E of 21 plus against its peer that quotes around 6 P/E and more that 2 P/BV. Read detail review...

Post Recommendation Manage Recommendations


  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.